American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 945-949, (2002)
© 2002 American Thoracic Society
Randomized Controlled Trial of Fluticasone in Preschool Children with Intermittent Wheeze
Caroline S. Pao and
Sheila A. McKenzie
Department of Respiratory Paediatrics, The Royal London Hospital, Whitechapel, London, United Kingdom
Correspondence and requests for reprints should be addressed to Sheila A. McKenzie, M.D., Department of Respiratory Paediatrics, Fielden House, The Royal London Hospital, Whitechapel, London E1 1BB, United Kingdom. E-mail: s.a.mckenzie{at}qmul.ac.uk
Preschool children with intermittent wheeze are often prescribed inhaled corticosteroids, although there is no proven benefit. Measurement of airway resistance by the interrupter technique can be used to objectively assess response to treatment. If lung function improves, treatment may be justified. Children with intermittent wheeze aged 2 to 5 years of age completed a 6-week randomized controlled crossover trial of fluticasone propionate (100 µg, twice daily), followed by a 10-week parallel extension. The relationships between changes in resistance, serum immunoglobulin E and sensitization measured by skin prick testing were investigated. Sixty-one children completed the crossover trial and 44 (72%) completed the extension. After 6 weeks, geometric mean change in resistance was -16.0% (95% confidence interval, -7.0 to -25.0%, p = 0.003) in sensitized children and -3.5% (95% confidence interval, +0.7 to -7.6%, p = 0.1) in nonsensitized children. Changes in resistance were unrelated to immunoglobulin E. Sixteen weeks after stopping fluticasone, resistance returned to baseline. This is the first study of preschool children with intermittent wheeze that has related changes in lung function on treatment to aeroallergen sensitization. Lung function improved in sensitized children and deteriorated after stopping treatment. Treatment with inhaled steroids may be justified in sensitized children.
Key Words: asthma child, preschool airway resistance skin test
This article has been cited by other articles:

|
 |

|
 |
 
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice
Am. J. Respir. Crit. Care Med.,
July 1, 2009;
180(1):
59 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A S Pelkonen, K Malmstrom, L P Malmberg, S Sarna, M Turpeinen, M Kajosaari, T Haahtela, and M J Makela
Budesonide improves decreased airway conductance in infants with respiratory symptoms
Arch. Dis. Child.,
July 1, 2009;
94(7):
536 - 541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Castro-Rodriguez and G. J. Rodrigo
Efficacy of Inhaled Corticosteroids in Infants and Preschoolers With Recurrent Wheezing and Asthma: A Systematic Review With Meta-analysis
Pediatrics,
March 1, 2009;
123(3):
e519 - e525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Ducharme, C. Lemire, F. J.D. Noya, G. M. Davis, N. Alos, H. Leblond, C. Savdie, J.-P. Collet, L. Khomenko, G. Rivard, et al.
Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children
N. Engl. J. Med.,
January 22, 2009;
360(4):
339 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beydon, S. D. Davis, E. Lombardi, J. L. Allen, H. G. M. Arets, P. Aurora, H. Bisgaard, G. M. Davis, F. M. Ducharme, H. Eigen, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1304 - 1345.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Guilbert, W. J. Morgan, R. S. Zeiger, D. T. Mauger, S. J. Boehmer, S. J. Szefler, L. B. Bacharier, R. F. Lemanske Jr., R. C. Strunk, D. B. Allen, et al.
Long-term inhaled corticosteroids in preschool children at high risk for asthma.
N. Engl. J. Med.,
May 11, 2006;
354(19):
1985 - 1997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Pharmacotherapy -- treatment of intermittent asthma with ICSs
Can. Med. Assoc. J.,
September 13, 2005;
173(6_suppl):
S33 - S36.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Teper, C. D. Kofman, G. A. Szulman, S. M. Vidaurreta, and A. F. Maffey
Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
587 - 590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Dundas, S A McKenzie, E Lombardi, and P D Sly
Interrupter resistance
Thorax,
May 1, 2004;
59(5):
449 - 450.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Y Chan, P D Bridge, I Dundas, C S Pao, M J R Healy, and S A McKenzie
Repeatability of airway resistance measurements made using the interrupter technique
Thorax,
April 1, 2003;
58(4):
344 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
333 - 344.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|